Evidence map›Paper›PMID 22395607›Full record

ArticleNature communications2012

Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.

Robert W Buckheit, Tracy G Allen, Angela Alme, Maria Salgado, Karen A O'Connell, Sarah Huculak, Oluwaseun Falade-Nwulia, Thomas M Williams, Joel E Gallant, Robert F Siliciano and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. CD8Nature reviews. Immunology · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Immune Control of HIV.Journal of life sciences (Westlake Village, Calif.) · 2019
    Article
  17. Review
  18. Article
  19. T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Robert W BuckheitDepartment of Medicine, Johns Hopkins University School of Medicine, 733 N. Broadway, BRB 880, Baltimore, Maryland 21205, USA.
Tracy G Allen
Angela Alme
Maria Salgado
Karen A O'Connell
Sarah Huculak
Oluwaseun Falade-Nwulia
Thomas M Williams
Joel E Gallant
Robert F Siliciano
Joel N Blankson

Funding

CD8+ T cell mediated inhibition of HIV-1 replication in Elite SuppressorsR01AI080328 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BLANKSON, JOEL N · 2009 to 2012
$1.3M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI080328
6 · The paper itself

Abstract

Viremic controllers and elite controllers/suppressors maintain control over HIV-1 replication. Some studies have suggested that control is a result of infection with a defective viral strain, while others suggested host immune factors have a key role. Here we document two HIV-1 transmission pairs: one consisting of a patient with progressive disease and an individual who became an elite suppressor, and the second consisting of a patient with progressive disease and a viremic controller. In contrast to another elite suppressor transmission pair, virus isolated from all patients was fully competent. These data suggest that some viremic controllers and elite suppressors are infected with HIV-1 isolates that replicate vigorously in vitro and are able to cause progressive disease in vivo. These data suggest that host factors have a dominant role in the control of HIV-1 infection, thus it may be possible to control fully pathogenic HIV-1 isolates with therapeutic vaccination.

Indexed as

HIV Long-Term SurvivorsVirus ReplicationAdultAmino Acid SequenceAntiretroviral Therapy, Highly ActiveBase SequenceCD4 Lymphocyte CountCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDisease ProgressionDisease SusceptibilityFemalegag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHost-Pathogen Interactionsgag Gene Products, Human Immunodeficiency Virus

Identifiers

PMID22395607
PMCPMC3549550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.